DMAC CIK: 1401040

DiaMedica Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.3
FY22:
−11.5
FY23:
−18.7
FY24:
−22.1
FY25:
−29.1
Change from FY21 to FY25
millions USD
FY21:
−20.5
FY22:
11.5
FY23:
−18.3
FY24:
8.56
FY25:
−2.19
Change from FY21 to FY25
millions USD
FY21:
30.1
FY22:
−0.01
FY23:
36.8
FY24:
12.0
FY25:
43.9
millions USD
FY21:
−2.70
FY22:
0.02
FY23:
−0.19
FY24:
−1.52
FY25:
12.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.3
FY22:
−11.6
FY23:
−18.8
FY24:
−22.1
FY25:
−29.1

All amounts in millions USD Data source:SEC EDGAR